Dutasteride for the Reduction of Alcohol Use in Male Drinkers
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether dutasteride is safe and effective for
reducing alcohol use in male drinkers who want to stop or reduce their drinking. The
investigators hypothesize that at a dosage of 1mg/day, dutasteride will be well tolerated and
that, compared to placebo treatment, dutasteride will result in a greater reduction in the
amount of alcohol consumed per week. The study sample size is of a pilot scale and is
designed to provide additional support for the study hypothesis and provide an estimate of
likely effect sizes in order to design a more definitive study.
Phase:
Phase 4
Details
Lead Sponsor:
UConn Health
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)